Cybersecurity

Scam Compound Trafficking Victim To Cybercrime Whistleblower: Mohammad Muzahir's Story

27 sec read3 views0 listens

Mohammad Muzahir's story details his escape from a scam compound where he was forced to run romance scams using AI deepfakes, and his subsequent role as a whistleblower. This highlights the real-world dangers of advanced scam operations and the human cost of cybercrime. For developers and tech professionals, this underscores the importance of ethical AI development and the ongoing fight against sophisticated fraud operations.

Read the full article at Cybercrime Magazine

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

STAT+: Pharmalittle: We're reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more

Cigna has announced it will no longer cover GLP-1 weight loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound in its employee health plan starting July 1, pushing users to pay out-of-pocket. This development underscores the growing trend of...

Ali Nemati

Beauty & Cosmetics2 days ago31 sec read

I Thought My Hyperpigmentation Was Acne Scarring - Until A Dermatologist Told Me Otherwise

Dermatosis papulosa nigra is a benign genetic skin condition prevalent across diverse ethnicities that presents as clustered, raised spots frequently misidentified as hyperpigmentation or acne scarring. This underscores a critical gap in diagnostic A...

Ali Nemati

Biotech & Pharma2 days ago28 sec read

Circio and GenAssist Collaborate on Gene Therapy for Muscle Disease and In Vivo Cell Therapy

Circio and GenAssist are collaborating to develop next-generation gene therapy candidates by integrating circular RNA technology with tissue-specific AAV vectors. This technical synergy allows developers to overcome the traditional dose-expression tr...

Ali Nemati

Biotech & Pharma3 days ago22 sec read

Pharma's Trial Problem: Outdated Systems, Broken Data, and the Coming AI Reset

Clinical trials in biopharmaceutical R&D are increasingly resource-intensive due to outdated systems and poor data management, despite advancements in science. AI could revolutionize this process but is hindered by the lack of structured, clinica...

Ali Nemati

Biotech & Pharma3 days ago21 sec read

Targeted Protein Degradation Broadens Its Scope

Targeted protein degradation (TPD) technologies are advancing to tackle extracellular proteins, expanding their therapeutic potential beyond intracellular targets. This development is crucial for addressing diseases driven by membrane-bound or secret...

Ali Nemati

Scam Compound Trafficking Victim To Cybercrime Whistleblower: Mohammad Muzahir's Story

Related Articles

STAT+: Pharmalittle: We're reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more

I Thought My Hyperpigmentation Was Acne Scarring - Until A Dermatologist Told Me Otherwise

Circio and GenAssist Collaborate on Gene Therapy for Muscle Disease and In Vivo Cell Therapy

Pharma's Trial Problem: Outdated Systems, Broken Data, and the Coming AI Reset

Targeted Protein Degradation Broadens Its Scope